SEC Form 4 · accession 0001144204-16-098705
NAVIDEA BIOPHARMACEUTICALS, INC. · NAVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gordon A Troup
Director
Period of report
Apr 20, 2016
Accepted (ET)
May 3, 2016 · 5:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000810509
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 20, 2016 | A | 28,000 | $0.00 | A | 265,568 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted Shares granted pursuant to the Issuer's 2014 Amended and Restated Stock Incentive Plan which vest on the one year anniversary of the date of grant.